株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

世界の心血管診断市場

The World Market for Cardiovascular Diagnostics (Markets for ECG, Imaging, Cardiac POC, Contrast Agents and Cardiac Markers)

発行 Kalorama Information 商品コード 274861
出版日 ページ情報 英文 180 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.71円で換算しております。
Back to Top
世界の心血管診断市場 The World Market for Cardiovascular Diagnostics (Markets for ECG, Imaging, Cardiac POC, Contrast Agents and Cardiac Markers)
出版日: 2013年06月26日 ページ情報: 英文 180 Pages
概要

当レポートでは、世界の心血管診断産業について調査し、成長を促進する動向、セグメント別の分析、各セグメントの市場規模・予測・年間成長率、産業に影響を及ぼす統計(世界の心臓病・関連疾患発生率、人口統計、寿命、企業戦略)などを示し、競合分析、主要企業のプロファイルなどを交え、概略以下の構成でお届けします。

第1章 エグゼクティブサマリー

第2章 産業概要

  • イントロダクション
  • 心血管の解剖学
  • 心臓疾患
  • 虚血性心臓疾患
  • 心臓弁膜・心内膜疾患
  • 心膜疾患
  • 心筋疾患
  • 先天性疾患
  • うっ血性心疾患
  • 不整脈
  • 高血圧

第3章 心電図記録法(ECG)

  • イントロダクション
  • 市場規模・成長率

第4章 心血管診断画像

  • 非侵襲性心血管画像
  • 侵襲性心血管画像
  • 市場規模・成長率

第5章 心血管診断のポイントオブケア検査

  • 凝固検査
  • コレステロール検査
  • 総市場規模・成長率

第6章 心血管マーカー

  • 総市場規模・成長率

第7章 心血管診断造影剤・放射性医薬品

  • 造影剤
  • 放射性医薬品
  • 総市場規模・成長率

第8章 市場参入企業

第9章 市場動向・サマリー

  • 市場概要
  • 市場収益:製品タイプ別
  • 世界の心血管診断市場分析:地域別
  • 競合分析

第10章 産業発展・技術

  • 人口統計
  • 世界の心血管疾患
  • 欧州の心血管疾患統計
  • 米国の人口統計
  • 新しい心血管CT装置
  • 造影剤の毒性
  • MRIカテーテルガイダンス
  • 医療制度改革、ほか

第11章 結論

企業リスト

図表リスト

目次
Product Code: KLI5068892

Abstract

This report, The World Market for Cardiovascular Diagnostics, provides the reader with an overview of the global cardiac diagnostics industry and the trends driving growth. Segments within the cardiac diagnostic market include:

  • Electrocardiography including ECG testing, stress testing, Holter monitoring, event monitoring and implantable loop.
  • Cardiac imaging including non-invasive X-Ray, MRI, CT, ultrasound, and nuclear cardiography; and invasive /cardiac catheterization/angiography, intravascular ultrasound, optical coherence technology and electrophysiology.
  • Cardiac point-of-care including cholesterol testing and coagulation testing
  • Cardiac markers
  • Cardiac contrast agents and radiopharmaceuticals

For each of these segments, market size and forecast, along with compound annual growth rate is provided. Also included in the report are statistics influencing the industry, incidence of cardiac and related diseases worldwide, demographics, life expectancy, and company strategies. Information is presented as a global market. A market summary includes a total market analysis. Also included is a competitive analysis of leading cardiac diagnostic providers.

Economic conditions in several markets within the global cardiac diagnostics market remained challenging in 2012. Demand for cardiovascular diagnostics slowed during the historical period due to a weakened global economy, cost cutting measures and healthcare reform issues. However, demographics worldwide and an aging world society remain primary factors in growth. By 2020, 16 percent of the US population will be over the age of 65, up from 13% in 2010. People are also living longer, needing more health care, further fueling the market. In 1980, the US life expectancy at birth was 74 years, today the average American lives to be 78 years old.

The global cardiac diagnostic industry is a diverse and highly competitive market. It is anticipated that provider demand for cardiac diagnostic products and services will continue to rise providing opportunities for both existing market participants and emerging market participants. Manufacturers should look for ways to distinguish themselves in the marketplace by keeping abreast of key market drivers, restraints, and trends that are affecting the market and the economy as a whole. More than ever before, manufacturers are facing survival challenges in today's marketplace while the need for innovative and safe products continues to grow.

Companies profiled in this report include:

  • Abbott Diagnostics
  • Acusphere
  • Alere
  • Analogic Corp
  • Bayer Healthcare
  • Bracco SpA
  • Cardinal Health
  • CardioDX
  • C.R. Bard
  • Danaher Corporation
  • dpiX
  • FluoroPharma Medical
  • GE Healthcare
  • Hitachi Medical Systems
  • Johnson & Johnson
  • King Pharmaceuticals
  • Lantheus Medical Imaging
  • LipScience
  • Medison America
  • Molecular Insight Pharmaceuticals
  • Nanosphere
  • PerkinElmer
  • Philips Healthcare
  • Roche Diagnostics
  • Shimadzu Corp
  • Siemens Medical Solutions
  • St Jude Medical
  • Terumo Medical
  • TomTec Imaging Systems
  • Toshiba
  • Trixell
  • Vascular Solutions
  • Vermillion
  • Volcano

Some of these companies are high stakes players in the market and control considerable market share while others are small or niche players that provide a valuable product to the global cardiac diagnostic arena. All are equally important to the market as a whole.

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with more than 21 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.

All market data pertains to the world market at the manufacturers' level. Revenues represent sales of diagnostics that pertain to the cardiovascular arena. The base year for data was 2012. Historical data was provided for the years 2010 and 2011, with forecast data provided for 2012 through 2017. Compound annual growth rates (CAGRs) are provided for the 2010-2012 and 2012-2017 periods for each region and/or segment covered. Competitive analysis is provided for the year 2012. The forecasted market analysis for 2012-2017 was largely based on demographic trends, new developments, company performance trends, merger and acquisitions, and national expansion.

Table of Contents

CHAPTER ONE: EXECUTIVE SUMMARY

  • Industry at a Glance
  • Scope and Methodology
  • Size and Growth of the Market
  • Key Issues and Trends Affecting the Market
  • Leading Market Participants

CHAPTER TWO: INDUSTRY OVERVIEW

  • Introduction
  • Cardiovascular Anatomy
  • Heart
  • Circulatory System
  • Cardiac Cycle
  • Coronary Circulation
  • Cardiac Myocytes
  • Molecular Contraction
  • Diseases of the Heart
  • Ischemic Heart Disease
  • Etiology
  • Pathophysiology
  • Atherosclerosis
  • Angina Pectoris
  • Acute Ischemia and Myocardial Infarction Chronic
  • Chronic Ischemic Cardiomyopathy
  • Sudden Cardiac Death
  • Diagnostic Tests
  • Valvular and Endocardial Diseases
  • Mitral Valve Disorders
  • Aortic Valve Disorders
  • Rheumatic Heart Disease
  • Endocarditis
  • Diagnostic Tests
  • Pericardial Diseases
  • Pericardial Effusion
  • Pericarditis
  • Myocardial Diseases
  • Myocarditis
  • Cardiomyopathy
  • Diagnostic Tests
  • Congenital Heart Diseases
  • Atrial Septal Defect
  • Ventral Septal Defect
  • Pulmonary Stenosis
  • Aortic Stenosis
  • Coarctation of the Aorta
  • Patent Ductus Arteriosus
  • Truncus Arteriosus
  • Transposition of the Great Arteries
  • Tricuspid Atresia
  • Congestive Heart Failure
  • Etiology
  • Diagnostic Tests
  • Cardiac Dysrhythmias
  • Diagnostic Tests
  • Hypertension
  • Risk Factors
  • Effects of High Blood Pressure

CHAPTER THREE: ELECTROCARDIOGRAPHY

  • Introduction
  • Market Size and Growth

CHAPTER FOUR: CARDIAC DIAGNOSTIC IMAGING

  • Non-Invasive Cardiac Imaging
  • X-Ray
  • MRI
  • Ultrasound
  • Computed Tomography
  • Electron Beam Computed Tomography
  • Dual Source Computed Tomography
  • Nuclear Cardiography
  • Invasive Transcatheter Cardiac Imaging
  • Cardiac Catheterization/Angiography Products
  • Intravascular Ultrasound
  • Optical Coherence Tomography
  • Electrophysiology
  • Market Size and Growth
  • Noninvasive Imaging
  • Invasive Transcatheter Imaging

CHAPTER FIVE: CARDIAC DIAGNOSTIC POINT OF CARE TESTING

  • Coagulation Testing
  • Cholesterol Testing
  • Total Cardiac Diagnostic Point-of- Care Market Size and Growth

CHAPTER SIX: CARDIAC MARKERS

  • Total Cardiac Markers Market Size and Growth

CHAPTER SEVEN: CARDIAC DIAGNOSTIC CONTRAST AGENTS AND RADIOPHARMACEUTICALS

  • Contrast Agents
  • Radiopharmaceuticals
  • Total Cardiac Diagnostic Contrast Agents and Radiopharmaceuticals Market Size and Growth

CHAPTER EIGHT: MARKET PARTICIPANTS

  • Summary
  • Abbott Diagnostics
  • Company Overview
  • Products
  • Acusphere
  • Alere, Inc
  • Company Overview
  • Products
  • Locations
  • Analogic Corp
  • Bayer Healthcare
  • Company Overview
  • Products
  • Bracco SpA
  • Cardinal Health
  • CardioDX, Inc
  • Company Overview
  • Products
  • C.R. Bard
  • Danaher Corporation
  • Company Overview
  • Products
  • dpiX, LLC
  • FluoroPharma Medical
  • GE Healthcare
  • Company Overview
  • Products and Services
  • Locations
  • Hitachi Medical Systems America, Inc.
  • Johnson & Johnson
  • Company Overview
  • Products
  • King Pharmaceuticals
  • Lantheus Medical Imaging
  • LipoScience, Inc
  • Company Overview
  • Products
  • Medison America, Inc.
  • Molecular Insight Pharmaceuticals, Inc.
  • Nanosphere, Inc.
  • Company Overview
  • Products
  • PerkinElmer
  • Philips Healthcare
  • Company Overview
  • Products and Services
  • Locations
  • Roche Diagnostics US (Div of Roche)
  • Company Overview
  • Products
  • Locations
  • Shimadzu Corp
  • Siemens Medical Solutions
  • Company Overview
  • Products and Services
  • St. Jude Medical
  • Company Overview
  • Products
  • Terumo Medical Corporation
  • TomTec Imaging Systems GmbH
  • Toshiba America Medical Systems, Inc
  • Company Overview
  • Products and Services
  • Trixell
  • Vascular Solutions
  • Vermillion, Inc
  • Company Overview
  • Products
  • Volcano Corp
  • Company Overview
  • Products
  • Locations

CHAPTER NINE: MARKET TRENDS AND SUMMARY

  • Market Overview
  • Market Revenues by Product Type
  • Global Cardiac Diagnostic Market Analysis by Region
  • United States
  • Europe
  • Japan
  • Rest of World
  • Competitive Analysis

CHAPTER TEN: INDUSTRY DEVELOPMENTS AND TECHNOLOGIES

  • Demographics
  • Cardiovascular Disease Worldwide
  • European Cardiovascular Disease Statistics
  • US-Specific Population Demographics
  • Population Over Age 65
  • Life Expectancy
  • Increasing Incidence of Disease
  • New Cardiac CT Device
  • CT Spots Seeds of Heart Disease in Healthy Patients
  • Contrast Agent Toxicity
  • Contrast Agents Generic Competition
  • MRI Catheter Guidance
  • Healthcare Reform

CHAPTER ELEVEN: CONCLUSIONS

LIST OF COMPANIES

LIST OF EXHIBITS

CHAPTER ONE:EXECUTIVE SUMMARY

  • Summary Table Global Cardiac Diagnostics Market Analysis, 2010-2017
  • Summary Figure Global Cardiac Diagnostics Market Analysis: 2010-2017

CHAPTER THREE: ELECTROCARDIOGRAPHY

  • Table 3-1 Total Electrocardiography Testing Market Analysis, 2010-2017
  • Figure 3-1 Total Electrocardiography Testing Market Analysis, 2010-2017

CHAPTER FOUR: IMAGING MARKET

  • Table 4-1 Non-Invasive Cardiac Imaging Market Analysis, 2010-2017
  • Table 4-2 Invasive Transcatheter Cardiac Imaging Market Analysis, 2010-2017
  • Table 4-3 Total Cardiac Diagnostic Imaging Market Analysis, 2010-2017
  • Figure 4-1 Total Cardiac Diagnostic Imaging Market Analysis, 2010-2017

CHAPTER FIVE: CARDIAC POINT OF CARE TESTING

  • Table 5-1 Cardiac Coagulation Testing Market Analysis, 2010-2017
  • Table 5-2 Cardiac Cholesterol Testing Market Analysis, 2010-2017
  • Table 5-3 Total Cardiac Diagnostic POC Testing Market Analysis, 2010-2017
  • Figure 5-1 Total Cardiac Diagnostic POC Testing Market Analysis, 2010-2017

CHAPTER SIX: CARDIAC MARKERS

  • Table 6-1 Total Cardiac Markers Market Analysis, 2010-2017
  • Figure 6-1 Total Cardiac Markers Market Analysis, 2010-2017

CHAPTER SEVEN: CARDIAC CONTRAST AGENTS

  • Table 7-1 Total Cardiac Diagnostic Contrast Agent and Radiopharmaceuticals Market Analysis,2010-2017
  • Figure 7-1 Total Cardiac Diagnostic Contrast Agent and Radiopharmaceuticals Market Analysis,2010-2017

CHAPTER NINE: MARKET TRENDS AND SUMMARY

  • Table 9-1 Global Cardiac Diagnostics Market Analysis, 2010-2017
  • Figure 9-1 Global Cardiac Diagnostics Market Analysis: 2010-2017
  • Table 9-2 Global Cardiac Diagnostics by Type Revenues and Percent of Market 2012 (in millions of dollars at the manufacturers' level)
  • Figure 9-2 Global Cardiac Diagnostics by Type Revenues and Percent of Market 2012
  • Table 9.3 Global Cardiac Diagnostic by Type Revenues and Percent of Market 2017 (in millions of dollars at the manufacturers' level)
  • Figure 9-3 Global Cardiac Diagnostics by Type Revenues and Percent of Market 2016
  • Table 9-4 Global Cardiac Diagnostics Market Revenues by Region 2012 ($millions)
  • Figure 9-4 Global Cardiac Diagnostics Market Revenues by Region 2012 ($millions)
  • Figure 9-5 Global Cardiac Diagnostics by Region Percent 2012 (%)
  • Table 9-5 Global Cardiac Diagnostics Market Revenues by Region 2017 ($millions)
  • Figure 9-6 Global Cardiac Diagnostics Market Revenues by Region 2017 ($millions)
  • Figure 9-7 Global Cardiac Diagnostics by Region Percent 2017 (%)
  • Table 9-6 Estimated Global Cardiac Diagnostics Manufacturer Market Share 2012
  • Figure 9-8 Estimated Global Cardiac Diagnostics Revenues and Market Share 2012

CHAPTER TEN: INDUSTRY DEVELOPMENTS AND TECHNOLOGIES ..165

  • Table 10-1 Total Global Population by Selected Geographical Region, 2000 - 2050
  • Table 10-2 Cardiovascular Deaths by World Region 2008
  • Table 10-3 The U.S. Population, 1980-2020
  • Figure 10-1 The US Population, 1980-2020 (in millions)
  • Table 10-4 Percent U.S. Population Over Age 65 by Year
  • Figure 10-2 Estimated Population by Age Group, 2000 and 2050
  • Table 10-5 Average U.S. Life Expectancy in Years 1980, 2004, 2006, 2010, 2011 (years)
  • Figure 10-3 Average U.S. Life Expectancy in Years 1980, 2004, 2006, 2010, 2011

APPENDIX

Back to Top